Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-04-07 00:00:00 ET · period of report 2025-04-04 · accession 0001649094-25-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-07 | 2025-04-04 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $8.96 | +20.5K | 518.8K | +4% | +$183.9K |
| DM | 2025-04-07 | 2025-04-04 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -20.5K | 186.9K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-04 | M | A | 15,781 | $5.35 | 514,023 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-04 | M | A | 4,752 | $20.93 | 518,775 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-04-04 | M | D | 4,752 | $0.00 | 298,360 | D | $20.93 · — to 2031-03-31 | 4,752 Common Stock | (F3) Stock Option is fully vested and exercisable. |
| 4 | Derivative | Stock Option (right to buy) | 2025-04-04 | M | D | 15,781 | $0.00 | 186,936 | D | $5.35 · — to 2030-04-17 | 15,781 Common Stock | (F3) Stock Option is fully vested and exercisable. |